|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-23 |
4 |
S |
$14.86 |
$8,990 |
I/I |
(605) |
15,168 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-01-25 |
4 |
B |
$6.00 |
$3,996 |
I/I |
666 |
15,372 |
1.42 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-10 |
4 |
B |
$4.83 |
$2,806 |
I/I |
581 |
15,724 |
1.42 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-03-23 |
4 |
B |
$4.96 |
$36,934 |
I/I |
7,447 |
15,743 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-17 |
4 |
S |
$14.80 |
$16,813 |
I/I |
(1,136) |
15,773 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-03-28 |
4 |
B |
$4.90 |
$417 |
I/I |
85 |
15,828 |
2.17 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-02-24 |
4 |
B |
$3.35 |
$28,914 |
I/I |
8,631 |
15,928 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-03-29 |
4 |
B |
$4.81 |
$4,304 |
I/I |
883 |
16,711 |
2.17 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-14 |
4 |
S |
$15.24 |
$8,032 |
I/I |
(527) |
16,909 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-06-01 |
4 |
S |
$3.86 |
$11,579 |
I/I |
(2,992) |
17,241 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-01 |
4 |
S |
$14.51 |
$4,383 |
I/I |
(302) |
17,436 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-11 |
4 |
B |
$5.28 |
$9,836 |
I/I |
1,864 |
17,588 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-06-30 |
4 |
S |
$14.99 |
$11,634 |
I/I |
(776) |
17,738 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-03-30 |
4 |
B |
$4.96 |
$5,627 |
I/I |
1,134 |
17,845 |
2.17 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-24 |
4 |
B |
$5.98 |
$2,322 |
I/I |
388 |
17,976 |
1.42 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-06-27 |
4 |
S |
$15.41 |
$157,290 |
I/I |
(10,207) |
18,514 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-04-29 |
4 |
B |
$3.99 |
$25,571 |
I/I |
6,393 |
19,030 |
2.25 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-25 |
4 |
B |
$6.00 |
$6,984 |
I/I |
1,164 |
19,140 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-05-04 |
4 |
B |
$4.79 |
$2,543 |
I/I |
531 |
19,561 |
2.17 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-05-29 |
4 |
S |
$4.12 |
$10,243 |
I/I |
(2,467) |
20,233 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-05-28 |
4 |
S |
$4.45 |
$20,752 |
I/I |
(4,626) |
22,700 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-08-03 |
4 |
B |
$5.71 |
$73,984 |
I/I |
12,952 |
22,971 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-08-10 |
4 |
B |
$5.32 |
$59,385 |
I/I |
11,167 |
23,136 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-08-11 |
4 |
B |
$5.42 |
$5,697 |
I/I |
1,049 |
24,185 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-08-03 |
4 |
B |
$5.71 |
$78,057 |
I/I |
13,665 |
24,236 |
2.25 |
- |
|
1397 Records found
|
|
Page 5 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|